Company: SVREW
Filing Date: 2025-07-08
Form Type: 424B3
Source: 0001213900-25-062089
Chunk: 21

Company: SaverOne 2014 Ltd.
Filing Date: 2025-07-08
Form: 424B3
Chunk 21
---
 to October 2026, our ADS will be subject to immediate delisting from Nasdaq.

In addition, we may in the
future fail to meet other continued Nasdaq listing requirements, and if we are not eligible to receive any compliance period from Nasdaq,
our ADS will be immediately delisted to over-the-counter market. If this were to occur, it would have a material adverse effect on our
business. Our shareholders could face significant material adverse consequences, including limited availability of market quotations for
ADSs and reduced liquidity for the trading of our securities. In addition, we could experience a decreased ability to issue additional
securities and obtain additional financing in the future. There can be no assurance that an active trading market for ADSs will develop
or be sustained. As a result of these factors, if the ADSs are delisted from Nasdaq, the price of the ADSs is most likely to decline.
The delisting of the ADSs from Nasdaq could also have other negative results, including the potential loss of confidence by employees,
the loss of institutional investor interest and fewer business development opportunities. If our ADSs are delisted from Nasdaq, we would
remain a publicly traded company on the TASE and revert to being subject to full Israeli securities laws and disclosure requirements.
Accordingly, we will need to comply with U.S. and Israeli disclosure requirements, and we expect that these additional reporting requirements
would increase our legal and financial compliance costs and require significant management time.

<div align='center'>10</div>

Risks Related to the Offering and Investment in our Securities

It is not possible to predict the actual number of ADSs we will sell under the SEPA to the Selling Shareholder, or the actual gross proceeds resulting from those sales. In addition, the sale and issuance of a substantial number of ADS by us to Yorkville could cause additional substantial dilution to our shareholders

On July 16, 2024, we entered
into the SEPA with Yorkville, pursuant to which Yorkville has committed to purchase up to $15.0 million in Ordinary Shares represented
by ADSs, subject to certain limitations and conditions set forth in the SEPA. As of the date of this Prospectus, we sold 3,445,791,290
Ordinary Shares represented by 957,165 (after giving retroactive effect of the new ratio of 3,600 ordinary shares for each ADS). The ADSs
that may be issued under the SEPA may be sold by us to York